These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37071585)

  • 1. Targeting multidrug resistant Staphylococcus aureus with cationic chlorpromazine-peptide conjugates.
    Panjla A; Kaul G; Akhir A; Saxena D; Joshi S; Modak C; Kumari D; Jain A; Chopra S; Verma S
    Chem Asian J; 2023 May; 18(10):e202300169. PubMed ID: 37071585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico identification of two peptides with antibacterial activity against multidrug-resistant Staphylococcus aureus.
    Oyama LB; Olleik H; Teixeira ACN; Guidini MM; Pickup JA; Hui BYP; Vidal N; Cookson AR; Vallin H; Wilkinson T; Bazzolli DMS; Richards J; Wootton M; Mikut R; Hilpert K; Maresca M; Perrier J; Hess M; Mantovani HC; Fernandez-Fuentes N; Creevey CJ; Huws SA
    NPJ Biofilms Microbiomes; 2022 Jul; 8(1):58. PubMed ID: 35835775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Cathelicidin-Mimetic Antimicrobial Peptoids against Staphylococcus aureus.
    Benjamin AB; Moule MG; Didwania MK; Hardy J; Saenkham-Huntsinger P; Sule P; Nielsen JE; Lin JS; Contag CH; Barron AE; Cirillo JD
    Microbiol Spectr; 2022 Jun; 10(3):e0053422. PubMed ID: 35467395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new dermaseptins with self-assembly tendency: membrane disruption, biofilm eradication, and infected wound healing efficacy.
    Song X; Pan H; Wang H; Liao X; Sun D; Xu K; Chen T; Zhang X; Wu M; Wu D; Gao Y
    Acta Biomater; 2020 Jun; 109():208-219. PubMed ID: 32276085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of arginine-phenylalanine and arginine-tryptophan-based surfactants against
    Moreno LS; Nascimento FB; da Silva CR; Sá LG; Neto JB; Silva J; Silva EM; Dos Santos HS; Pérez L; da Silva AR; Rodrigues DS; Barbosa AD; Moreira LE; Cavalcanti BC; de Morais MO; Júnior HV
    Future Microbiol; 2022 Nov; 17():1363-1379. PubMed ID: 36169348
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic resistance and drug modification: Synthesis, characterization and bioactivity of newly modified potent pleuromutilin derivatives with a substituted piperazine moiety.
    Yi Y; Yang S; Liu Y; Yin B; Zhao Z; Li G; Huang Z; Chen L; Liu F; Shang R; Lin S
    Bioorg Chem; 2023 Mar; 132():106353. PubMed ID: 36669358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel membrane-disruptive antimicrobial peptide from frog skin secretion against cystic fibrosis isolates and evaluation of anti-MRSA effect using Galleria mellonella model.
    Yuan Y; Zai Y; Xi X; Ma C; Wang L; Zhou M; Shaw C; Chen T
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):849-856. PubMed ID: 30802593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New mechanism of magnolol and honokiol from Magnolia officinalis against Staphylococcus aureus.
    Liu T; Pan Y; Lai R
    Nat Prod Commun; 2014 Sep; 9(9):1307-9. PubMed ID: 25918799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3-alkylpyridine-bearing alkaloid exhibits potent antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) with no detectable resistance.
    Herrera KMS; Lopes GFM; Oliveira ME; Sousa JF; Lima WG; Silva FK; Brito JCM; Gomes AJPS; Viana GHR; Soares AC; Ferreira JMS
    Microbiol Res; 2022 Aug; 261():127073. PubMed ID: 35636092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial and antibiofilm activities of thiazolidine-2,4-dione and 4-thioxo-thiazolidin-2-one derivatives against multidrug-resistant Staphylococcus aureus clinical isolates.
    Sena KXFR; Mendes RFV; Bôtelho EX; Araújo-Melo RO; Silva CJA; Costa Júnior HNP; Amorim-Carmo B; Damasceno IZ; Fernandes-Pedrosa MF; Aguiar JS; Silva TG; Lima GMS; Albuquerque JFC; Ximenes RM
    J Appl Microbiol; 2022 Dec; 133(6):3558-3572. PubMed ID: 36000385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, antimicrobial susceptibility pattern and multidrug resistance of methicillin-resistant
    Adhikari P; Basyal D; Rai JR; Bharati L; Budthapa A; Gharti KP; Sah SK
    BMJ Open; 2023 May; 13(5):e067384. PubMed ID: 37164471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting druggable enzymome by exploiting natural medicines: An in silico-in vitro integrated approach to combating multidrug resistance in bacterial infection.
    Zang P; Gong A; Zhang P; Yu J
    Pharm Biol; 2016; 54(4):604-18. PubMed ID: 26681298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hinokiflavone Attenuates the Virulence of Methicillin-Resistant Staphylococcus aureus by Targeting Caseinolytic Protease P.
    Kong X; Wang B; Chen X; Wang L; Wang X; Hou J; Wei L; Sui L; Zhang C; Guan J; Luan Y; Wang W; Song W; Zhao Y
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0024022. PubMed ID: 35862746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiating effect of Mentha arvensis and chlorpromazine in the resistance to aminoglycosides of methicillin-resistant Staphylococcus aureus.
    Coutinho HD; Costa JG; Lima EO; Falcão-Silva VS; Siqueira-Júnior JP
    In Vivo; 2009; 23(2):287-9. PubMed ID: 19414416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug design based on pentaerythritol tetranitrate reductase: synthesis and antibacterial activity of Pogostone derivatives.
    Wang B; Huang W; Zhou J; Tang X; Chen Y; Peng C; Han B
    Org Biomol Chem; 2017 Aug; 15(31):6548-6556. PubMed ID: 28745773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Temporin Derived Peptide Showing Antibacterial and Antibiofilm Activities against
    An M; Guo R; Xie S; Wang J; Song Y; Wang R; Jiang W; Wei S; Zhang Y
    Protein Pept Lett; 2023; 30(2):183-192. PubMed ID: 36476441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antibacterial Potential of Ciprofloxacin Hybrids against
    Zang W; Li D; Gao L; Gao S; Hao P; Bian H
    Curr Top Med Chem; 2022; 22(12):1020-1034. PubMed ID: 35301951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Update on
    Monteiro KLC; de Aquino TM; Mendonça Junior FJB
    Curr Top Med Chem; 2020; 20(24):2168-2185. PubMed ID: 32621719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
    Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
    Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.
    Escaich S; Prouvensier L; Saccomani M; Durant L; Oxoby M; Gerusz V; Moreau F; Vongsouthi V; Maher K; Morrissey I; Soulama-Mouze C
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4692-7. PubMed ID: 21825292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.